FDA Adverse Event Malfunction Summary report: N

BD Q-SYTE CLOSED LUER ACCESS DEVICE

MDR report key: 21925001 · Received April 29, 2025

Report

Report Number
1710034-2025-00696
Event Type
Malfunction
Date Received
April 29, 2025
Date of Event
March 1, 2025
Report Date
April 15, 2025
Manufacturer
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
Product Code
FPA
UDI-DI
00382903851003
PMA / PMN Number
K013621
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

NO PHOTOS OR PHYSICAL SAMPLES THAT DISPLAY THE REPORTED CONDITION WERE AVAILABLE FOR INVESTIGATION. A DEVICE HISTORY RECORD REVIEW WAS COMPLETED BY OUR QUALITY ENGINEER TEAM FOR PROVIDED MATERIAL NUMBER 385100 AND LOT NUMBER 4100572. THE REVIEW DID NOT REVEAL ANY DETECTED ABNORMALITIES DURING THE PRODUCTION PROCESS THAT COULD HAVE CONTRIBUTED TO THIS DEFECT AND ALL QUALITY TESTS WERE FOUND TO BE WITHIN SPECIFICATION. BASED ON THE AVAILABLE INFORMATION, AN EXACT CAUSE FOR THIS INCIDENT COULD NOT BE IDENTIFIED. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. OUR QUALITY TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT BD Q-SYTE CLOSED LUER ACCESS DEVICE LEAKED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: ON (B)(6) 2025, THE NURSE GAVE THE PATIENT AN INDWELLING PICC LINE FOR SEALING AT THE END OF THE INFUSION AND FOUND THAT THERE WAS A LEAK AT THE HEPARIN CAP, REPLACED THE HEPARIN CAP, AND COMPLETED SEALING THE LINE, AND THIS ADVERSE EVENT DID NOT CAUSE ANY OTHER ADVERSE EFFECTS TO THE PATIENT AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
481035 BD Q-SYTE CLOSED LUER ACCESS DEVICE SET, ADMINISTRATION, INTRAVASCULAR FPA BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 4100572 00382903851003

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown